SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-010842
Filing Date
2021-05-10
Accepted
2021-05-10 08:00:42
Documents
84
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 937042
2 ex10-1.htm EX-10.1 17756
3 ex10-2.htm EX-10.2 543181
4 ex10-3.htm EX-10.3 71567
5 ex31-1.htm EX-31.1 17628
6 ex31-2.htm EX-31.2 18024
7 ex32-1.htm EX-32.1 6195
8 ex32-2.htm EX-32.2 6259
9 ex10-2_001.jpg GRAPHIC 3451
  Complete submission text file 0001493152-21-010842.txt   5724791

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE vbiv-20210331.xsd EX-101.SCH 52105
11 XBRL CALCULATION FILE vbiv-20210331_cal.xml EX-101.CAL 67431
12 XBRL DEFINITION FILE vbiv-20210331_def.xml EX-101.DEF 174906
13 XBRL LABEL FILE vbiv-20210331_lab.xml EX-101.LAB 370104
14 XBRL PRESENTATION FILE vbiv-20210331_pre.xml EX-101.PRE 290685
15 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 626355
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 21905299
SIC: 2834 Pharmaceutical Preparations